SYRE
Spyre Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
4.33 / 10Overall Score
NeturalInvestment Rating
4.33 / 10Overall Score
NeturalInvestment Rating
Trend Analysis of SYRE
- Based on a composite score of 4.33/10, we rate SYRE as a Netural. Our analysis breaks down into 3.96/10 for Fundamentals, 2.96/10 for Technicals, and 5.21/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of SYRE?
Is SYRE undervalued or overvalued?
Is money flowing into or out of SYRE?
Trend Analysis of SYRE
- Based on a composite score of 4.33/10, we rate SYRE as a Netural. Our analysis breaks down into 3.96/10 for Fundamentals, 2.96/10 for Technicals, and 5.21/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is SYRE undervalued or overvalued?
Technical Analysis of SYRE?
Is money flowing into or out of SYRE?
